L. Mindeholm

发表

Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study

D. Newitt, E. Eriksen, C. Chesnut, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology‐Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3‐Month Effects on Biomarkers of Bone Turnover

C. Christiansen, J. Reginster, L. Tankó, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Assessment of bone quality, quantity, and turnover with multiple methodologies at multiple skeletal sites.

S. Majumdar, D. Newitt, C. Chesnut, 2001, Advances in experimental medicine and biology.

The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients

D. Chappard, M. Baslé, M. Audran, 2009, Microscopy research and technique.

AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women.

K. Seuwen, J. Mason, J. Loeffler, 2014, Bone.

The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women.

B. Kiese, A. Launonen, M. Azria, 2012, Bone.

Serum growth hormone (GH) profiles after nasally administered GH in normal subjects and GH deficient patients

J. Jørgensen, J. Christiansen, L. Mindeholm, 1994, Clinical endocrinology.

Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study

C. Janson, K. Larsson, Bine Kjøller Bjerregaard, 2020, European Respiratory Journal.